+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment

Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment

Oncotarget 6(34): 36603-36614

Experiments were performed in a modified microfluidic platform recapitulating part of the in vivo tumor microenvironment by co-culturing carcinoma cell aggregates embedded in a three-dimensional (3D) collagen scaffold with human umbilical vein endothelial cells (HUVECs). HUVECs were seeded in one channel of the device to initiate vessel-like structures in vitro prior to introducing the aggregates. The lung adenocarcinoma cell line A549 and the bladder carcinoma cell line T24 were tested. Dose-response assays of four drugs known to interfere with Epithelial Mesenchymal Transition (EMT) signaling pathways were quantified using relative dispersion as a metric of EMT progression. The presence of HUVECs in one channel induces cell dispersal in A549 which then can be inhibited by each of the four drugs. Complete inhibition of T24 aggregate dispersal, however, is not achieved with any single agent, although partial inhibition was observed with 10 μM of the Src inhibitor, AZD-0530. Almost complete inhibition of T24 dispersal in monoculture was achieved only when the four drugs were added in combination, each at 10 μM concentration. Coculture of T24 with HUVECs forfeits the almost-complete inhibition. The enhanced dispersal observed in the presence of HUVECs is a consequence of secretion of growth factors, including HGF and FGF-2, by endothelial cells. This 3D microfluidic co-culture platform provides an in vivo-like surrogate for anti-invasive and anti-metastatic drug screening. It will be particularly useful for defining combination therapies for aggressive tumors such as invasive bladder carcinoma.

(PDF emailed within 1 workday: $29.90)

Accession: 058039152

Download citation: RISBibTeXText

PMID: 26474384

Related references

Single agents or combination chemotherapy for advanced ovarian carcinoma in elderly patients: pro single agents. Tumori 88(1 Suppl 1): S117-S119, 2002

Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination. International Journal Of Cancer. 57(3): 392-398, 1994

Human tumor-cell growth modulatory effects of the aebs/hic-binding drugs used as single agents and in combination with a novel amphibian oocyte rnase. International Journal of Oncology 2(5): 807-812, 1993

Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma. European Journal of Cancer 36(7): 817-820, 2000

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary. Plos One 11(3): E0151050, 2016

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. Journal of Clinical Oncology 10(2): 257-263, 1992

Biochemopreventive combination may have synergistic effects over single-agents or 2-drug combinations in vitro culture of squamous cell carcinoma of the head and neck cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 311, 2002

Care during surgery for carcinoma of the bladder with tumor-free technique to prevent medical dissemination. Zhonghua Hu Li Za Zhi 29(9): 530-532, 1994

Nonagglutinating vibrios etiologic agents of diarrheic disease their presence and dissemination in the external physical environment. Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie Serie Igiena 29(2): 135-140, 1980

A microfluidic digital single-cell assay for the evaluation of anticancer drugs. Analytical and Bioanalytical Chemistry 407(4): 1139-1148, 2015

A case of gastric cancer with peritoneal dissemination who achieved five-year survival by successive treatments with TS-1 alone and in combination with other drugs. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(2): 239-242, 2006

Measurement of surface-mediated Ca2+ transients on the single-cell level in a microfluidic lab-on-a-chip environment. Methods in Molecular Biology 1272: 247-256, 2015

Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies. Current Molecular Pharmacology 3(3): 98-122, 2011

Tumour cell identification by means of Raman spectroscopy in combination with optical traps and microfluidic environments. Lab on a Chip 11(8): 1484-1490, 2011

Quartz microfluidic chip for tumour cell identification by Raman spectroscopy in combination with optical traps. Analytical and Bioanalytical Chemistry 405(8): 2743-2746, 2013